The  Transcriptomics Technologies Market  reached USD 3.98 Billion in 2022 and is poised to attain USD 9.78 Billion by 2032, depicting a notable revenue Compound Annual Growth Rate (CAGR) of 10.5% over the forecast period. The growth in market revenue is propelled by significant factors such as the escalating demand for personalized treatments and increased investments in genomics...